Skip to main content

Animations

MJFF Publications

1641 - 1650 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8
    Best OA location URL:
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
    Journal Name: Genome Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13073-022-01132-9
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-34667-x
    Citation Count: 187
  • Summary Details
    OPEN
    Title: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms232214018
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic Review
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29278
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Movement Disorders andSARS‐CoV‐2
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13615
    Citation Count: 3
  • Summary Details
    OPEN
    Title: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00411-x
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms232213985
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease
    Journal Name: Neuropsychologia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.